3D / Structural Protein ML Scientist

Nabla Bio

At Nabla, we are building the next generation of antibody therapeutics through design, not discovery.

Antibodies need to possess a multitude of properties to be manufacturable, safe, and efficacious for patients. This is a hard engineering problem with a high a failure rate, because today’s discovery technologies rely on brute-force guess-and-check. At Nabla, we're building a protein design platform that enables us to build antibodies deliberately, with all the properties they need to reach and treat patients, and do so faster than we can today.

The role

• Developing ML methods to predict and design antibody-antigen interactions
• Develop structure-informed representations that enable multi-property antibody engineering
• Doing the above in tight design-build-test cycles with our wet-lab

What makes this role different?

We can experimentally measure multiple properties of 1000s of designs quickly. This allows us to quantitatively A/B test your ideas and measure progress regularly.